U.S. aid cuts halt HIV vaccine research in South Africa, with global impact

South Africa has been hit especially hard because of Mr. Trump's baseless claims about the targeting of the country's white Afrikaner minority. The country had been receiving about $400 million a year via USAID and the HIV-focused PEPFAR

World